The Cadillac Formula 1 Team has announced a multi-year partnership with Core Scientific, which joins the organisation as its Official Data Centre Partner.
The collaboration will see Core Scientific advise on the development of the team’s primary US data hub at its new headquarters in Indianapolis.
Core Scientific will help design and optimise the infrastructure required to support the computing demands of a modern F1 operation.
F1 teams rely heavily on high-performance computing to run simulations, analyse engineering data and support race operations.
“Cadillac Formula 1 Team’s entry into Formula 1 marks a historic moment in American motorsport,” said Adam Sullivan, Chief Executive Officer at Core Scientific.
“We’re proud to support the team’s data and technology strategy through our expertise in designing, building and operating high-density data centres engineered for the world’s most demanding workloads.”
For Cadillac, the partnership forms part of the broader process of building a new F1 team and Tyler Epp, Global Head of Commercial Strategy, said the opportunity to design systems from scratch provides a competitive advantage.
“Building an F1 team from the ground up offers us the opportunity to build custom-fit systems and processes for the task in hand,” he said.
Building an F1 team from the ground up offers us the opportunity to build custom-fit systems and processes for the task in hand.
Tyler Epp
“We are pleased to work with Core Scientific to create the best infrastructure solutions to realise our future ambitions.”
Under the agreement, Core Scientific will provide guidance and expertise to ensure the team’s infrastructure is secure, scalable and capable of supporting high-density computing workloads, as well as hybrid cloud environments connecting the team’s facilities in the US and the United Kingdom.
In July last year, a $9billion all-stock acquisition of Core Scientific was announced by CoreWeave – Aston Martin Aramco F1 Team’s Official AI Cloud Computing Partner – before being terminated in October after Core Scientific shareholders voted against the proposal.
